|
Intco Medical Technology Co., Ltd. (300677.SZ) Valoración de DCF |
Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
Predeterminadas Para Un Uso Rápido Y Eficiente
Compatible con MAC / PC, completamente desbloqueado
No Se Necesita Experiencia; Fáciles De Seguir
Intco Medical Technology Co., Ltd. (300677.SZ) Bundle
Ya sea que sea un inversor o analista, esta calculadora DCF (300677SZ) es su herramienta de referencia para una valoración precisa. Con datos reales de Intco Medical Technology Co., Ltd., puede ajustar los pronósticos e inmediatamente ver los efectos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13,836.7 | 16,240.1 | 6,613.8 | 6,918.7 | 9,523.3 | 9,531.7 | 9,540.0 | 9,548.4 | 9,556.7 | 9,565.1 |
| Revenue Growth, % | 0 | 17.37 | -59.27 | 4.61 | 37.65 | 0.08764176 | 0.08764176 | 0.08764176 | 0.08764176 | 0.08764176 |
| EBITDA | 8,511.2 | 9,038.1 | 1,367.4 | 1,166.5 | 2,779.4 | 3,505.5 | 3,508.5 | 3,511.6 | 3,514.7 | 3,517.8 |
| EBITDA, % | 61.51 | 55.65 | 20.68 | 16.86 | 29.19 | 36.78 | 36.78 | 36.78 | 36.78 | 36.78 |
| Depreciation | 140.1 | 368.3 | 631.1 | 723.5 | 862.5 | 616.4 | 617.0 | 617.5 | 618.1 | 618.6 |
| Depreciation, % | 1.01 | 2.27 | 9.54 | 10.46 | 9.06 | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 |
| EBIT | 8,371.1 | 8,669.8 | 736.3 | 443.0 | 1,917.0 | 2,889.0 | 2,891.6 | 2,894.1 | 2,896.6 | 2,899.2 |
| EBIT, % | 60.5 | 53.39 | 11.13 | 6.4 | 20.13 | 30.31 | 30.31 | 30.31 | 30.31 | 30.31 |
| Total Cash | 6,390.4 | 8,277.0 | 6,657.1 | 13,181.4 | 18,751.5 | 7,571.0 | 7,577.7 | 7,584.3 | 7,590.9 | 7,597.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 699.5 | 775.2 | 555.4 | 1,127.7 | 1,457.3 | 949.9 | 950.7 | 951.5 | 952.4 | 953.2 |
| Account Receivables, % | 5.06 | 4.77 | 8.4 | 16.3 | 15.3 | 9.97 | 9.97 | 9.97 | 9.97 | 9.97 |
| Inventories | 847.5 | 1,079.0 | 1,003.9 | 1,150.0 | 1,265.4 | 1,102.9 | 1,103.9 | 1,104.9 | 1,105.8 | 1,106.8 |
| Inventories, % | 6.12 | 6.64 | 15.18 | 16.62 | 13.29 | 11.57 | 11.57 | 11.57 | 11.57 | 11.57 |
| Accounts Payable | 856.1 | 1,237.5 | 910.1 | 767.4 | 845.4 | 906.2 | 907.0 | 907.8 | 908.6 | 909.4 |
| Accounts Payable, % | 6.19 | 7.62 | 13.76 | 11.09 | 8.88 | 9.51 | 9.51 | 9.51 | 9.51 | 9.51 |
| Capital Expenditure | -2,888.8 | -5,443.6 | -1,715.2 | -1,438.7 | -1,789.4 | -2,286.0 | -2,288.0 | -2,290.0 | -2,292.0 | -2,294.0 |
| Capital Expenditure, % | -20.88 | -33.52 | -25.93 | -20.79 | -18.79 | -23.98 | -23.98 | -23.98 | -23.98 | -23.98 |
| Tax Rate, % | 8.92 | 8.92 | 8.92 | 8.92 | 8.92 | 8.92 | 8.92 | 8.92 | 8.92 | 8.92 |
| EBITAT | 7,027.6 | 7,448.2 | 657.6 | 383.2 | 1,746.1 | 2,523.5 | 2,525.7 | 2,527.9 | 2,530.2 | 2,532.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 3,588.0 | 2,447.1 | -459.1 | -1,193.2 | 452.1 | 1,584.6 | 853.7 | 854.5 | 855.2 | 856.0 |
| WACC, % | 7.33 | 7.36 | 7.42 | 7.37 | 7.46 | 7.39 | 7.39 | 7.39 | 7.39 | 7.39 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 4,148.3 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 882 | |||||||||
| Terminal Value | 20,093 | |||||||||
| Present Terminal Value | 14,070 | |||||||||
| Enterprise Value | 18,218 | |||||||||
| Net Debt | 819 | |||||||||
| Equity Value | 17,399 | |||||||||
| Diluted Shares Outstanding, MM | 648 | |||||||||
| Equity Value Per Share | 26.83 |
Benefits of Using Our Template
- Flexible Forecast Inputs: Effortlessly adjust key assumptions (growth %, profit margins, WACC) to explore various scenarios.
- Comprehensive Financial Data: Intco Medical Technology’s financials pre-loaded to facilitate your analysis.
- Automated DCF Calculations: The template generates Net Present Value (NPV) and intrinsic value automatically for you.
- Tailored and Professional Design: A sleek Excel model that customizes to fit your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Current AAPL Data: Pre-loaded with Intco Medical Technology’s historical financial data and future projections.
- Fully Adjustable Inputs: Modify revenue growth rates, profit margins, WACC, tax percentages, and capital expenditures.
- Dynamic Valuation Model: Automatically updates Net Present Value (NPV) and intrinsic value according to your adjustments.
- Scenario Testing: Develop various forecast scenarios to evaluate different valuation results.
- User-Friendly Interface: Intuitive, organized, and suitable for both professionals and newcomers.
How It Operates
- Step 1: Download the prebuilt Excel template featuring Intco Medical Technology Co., Ltd.'s data.
- Step 2: Navigate through the pre-filled sheets and familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalibrated results, including Intco Medical Technology Co., Ltd.'s intrinsic value.
- Step 5: Make well-informed investment decisions or create reports based on the outputs.
Why Choose This Calculator for Intco Medical Technology Co., Ltd. (300677SZ)?
- User-Friendly Interface: Perfect for both novices and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your financial analysis.
- Real-Time Valuation Updates: Watch instant changes to Intco’s valuation as you tweak inputs.
- Pre-Loaded Data: Comes with Intco’s actual financial metrics for rapid analysis.
- Preferred by Experts: Widely used by investors and analysts to guide their decisions.
Who Can Benefit from This Product?
- Professional Investors: Create comprehensive and accurate valuation models for analyzing portfolios with Intco Medical Technology (300677SZ).
- Corporate Finance Teams: Evaluate valuation scenarios to inform and refine internal strategies at Intco Medical Technology (300677SZ).
- Consultants and Advisors: Deliver precise valuation insights to clients regarding Intco Medical Technology (300677SZ) stock.
- Students and Educators: Utilize real-world data to learn and teach financial modeling using Intco Medical Technology (300677SZ).
- Healthcare Industry Enthusiasts: Gain insights into how companies like Intco Medical Technology (300677SZ) are valued in the marketplace.
What the Template Contains
- Pre-Filled DCF Model: Intco Medical Technology’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Assess Intco Medical Technology’s profitability, leverage, and efficiency.
- Editable Inputs: Modify assumptions such as growth rates, margins, and CAPEX to tailor your scenarios.
- Financial Statements: Comprehensive annual and quarterly reports for in-depth analysis.
- Interactive Dashboard: Effortlessly visualize key valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.